In May perhaps 2019, a trial at Nanjing University Medical center commenced comparing dapagliflozin to liraglutide, and also to the anti-diabetic medication acarbose, for their respective outcomes on cognitive and olfactory function in 87 overweight persons whose Sort 2 diabetes is inadequately managed with metformin by yourself. 知乎，让每一次点击都充满意义 —— 欢迎来到知乎，发现问题... https://devendral666yiu8.evawiki.com/user